Provenance Wealth Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2081584
FORT LAUDERDALE, FL
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$125,331
-$29,197 QoQ
Shares Held
201
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,077
of 1,322 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Provenance Wealth Advisors, LLC holds $131,838 across 3 Biotechnology names. REGN ranks #1 (95.1% of the industry book) .
All Filings in REGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,331 | 201 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $154,528 | 200 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $154,374 | 200 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $112,454 | 200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $105,000 | 200 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $126,846 | 200 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $142,466 | 200 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $210,248 | 200 | Shares | Sole | 2025-08-15 | |
| 2024-06-30 | $210,206 | 200 | Shares | Sole | 2025-08-15 | |
| 2024-03-31 | $192,498 | 200 | Shares | Sole | 2025-08-15 | |
| 2023-12-31 | $175,658 | 200 | Shares | Sole | 2025-08-15 | |
| 2023-09-30 | $164,592 | 200 | Shares | Sole | 2025-08-15 | |
| No filing history on record for this holder in this stock. | ||||||